Inventor · disambiguated record
Michael J. Caplan
Also filed as: CAPLAN MICHAEL · CAPLAN MICHAEL J
14 granted patents·20 pending applications·752 citations·filing 1996–2022
94Inventor score
Top patents by PatentIndex Score
34 records- 0196US6329150B1Unimolecular segment amplification and sequencingUNIV YALE·Filed 2000·Granted Dec 11, 2001·162 cites·43 claims
- 0296US6143495AUnimolecular segment amplification and sequencingUNIV YALE·Filed 1996·Granted Nov 7, 2000·424 cites·58 claims
- 0392US8815251B2Microbial delivery systemALLERTEIN THERAPEUTICS LLC·Filed 2013·Granted Aug 26, 2014·20 cites·2 claims
- 0491US9597385B2Nanoparticles for treatment of allergyALLERTEIN THERAPEUTICS LLC·Filed 2013·Granted Mar 21, 2017·8 cites·7 claims
- 0591US8246945B2Methods and reagents for decreasing clinical reaction to allergyCAPLAN MICHAEL J·Filed 2009·Granted Aug 21, 2012·17 cites·24 claims
- 0690US8889117B2Modular nanoparticles for adaptable vaccinesMELLMAN IRA S·Filed 2008·Granted Nov 18, 2014·26 cites·18 claims
- 0784US9999600B2Nanoparticle compositionsN FOLD LLC·Filed 2016·Granted Jun 19, 2018·6 cites·9 claims
- 0882US9539217B2Nanoparticle compositionsALLERTEIN THERAPEUTICS LLC·Filed 2014·Granted Jan 10, 2017·5 cites·20 claims
- 0982US8153414B2Microbial delivery systemCAPLAN MICHAEL J·Filed 2000·Granted Apr 10, 2012·16 cites·5 claims
- 1079US10265407B2Modular nanodevices for smart adaptable vaccinesUNIV YALE·Filed 2014·Granted Apr 23, 2019·1 cites·28 claims
- 1174US6344475B1Conductance of improperly folded proteins through the secretory pathwayUNIV YALE·Filed 1999·Granted Feb 5, 2002·40 cites·48 claims
- 1272US11071776B2Nanoparticles for treatment of allergyN FOLD LLC·Filed 2019·Granted Jul 27, 2021·0 cites·17 claims
- 1367US8058314B2Conductance of improperly folded proteins through the secretory pathway and related methods for treating diseaseCAPLAN MICHAEL J·Filed 2007·Granted Nov 15, 2011·1 cites·10 claims
- 1463US2003235849A1Unimolecular segment amplification and sequencingFiled 2003·Application pending·0 cites
- 1561US6299875B1Methods to block IGE binding to cell surface receptors of mast cellsPANACEA PHARM LLC·Filed 1998·Granted Oct 9, 2001·26 cites·11 claims
- 1660US2019117793A1Modular nanodevices for smart adaptable vaccinesUNIV YALE·Filed 2018·Application pending·0 cites
- 1759US2017224801A1Nanoparticles for treatment of allergyALLERTEIN THERAPEUTICS LLC·Filed 2017·Application pending·0 cites
- 1858US2024400627A1Compositions and methods for the treatment of autosomal dominant polycystic kidney disease and other diseases having upregulated mtor activityUNIV YALE·Filed 2022·Application pending·0 cites
- 1958US2013142817A1Microbial delivery systemCAPLAN MICHAEL J·Filed 2012·Application pending·0 cites
- 2057US2004234548A1Microbial delivery systemFiled 2003·Application pending·0 cites
- 2157US2004156821A1System for controlling immune system response to antigenFiled 2004·Application pending·0 cites
- 2256US2004208894A1Microbial delivery systemCAPLAN MICHAEL J·Filed 2003·Application pending·0 cites
- 2355US2005063994A1Methods and reagents for decreasing clinical reaction to allergyFiled 2004·Application pending·0 cites
- 2453US2011027298A1Microbial delivery systemALLERTEIN THERAPEUTICS LLC·Filed 2010·Application pending·0 cites
- 2553US2016228521A1Managing immune responses in transplantationALLERTEIN THERAPEUTICS LLC·Filed 2014·Application pending·0 cites
- 2651US2012283421A1Methods and reagents for decreasing clinical reaction to allergyCAPLAN MICHAEL J·Filed 2011·Application pending·0 cites
- 2750US2004266883A1Conductance of improperly folded proteins through the secretory pathway and related methods for treating diseaseUNIV YALE·Filed 2004·Application pending·0 cites
- 2850US2003202980A1Methods and reagents for decreasing clinical reaction to allergyFiled 2002·Application pending·0 cites
- 2948US2021077617A1Immune modulationN FOLD LLC·Filed 2019·Application pending·0 cites
- 3047US2003236300A1Conductance of improperly folded proteins through the secretory pathway and related methods for treating diseaseUNIV YALE·Filed 2003·Application pending·0 cites
- 3144US2001031262A1Controlled delivery of antigensFiled 2000·Application pending·0 cites
- 3238US2001051155A1Methods and compositions for decreasing allergic reactions to surface allergensFiled 2001·Application pending·0 cites
- 3330US2002076420A1Methods to block IgE binding to cell surface receptors of mast cellsFiled 2001·Application pending·0 cites
- 3428US2002090381A1System for controlling immune system response to antigenFiled 1999·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael J. Caplan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →